Role of oxidative stress in development of complications in diabetes

• Published in: Diabetes (New York, N.Y.) Vol. 40; no. 4; pp. 405 - 412
• Main Author: BAYNES, J. W
• Format: Journal Article
• Language: English
• Published: Alexandria, VA American Diabetes Association 01-04-1991
• Subjects: Associated diseases and complications; Biological and medical sciences; Collagen - physiology; Diabetes Complications; Diabetes Mellitus - physiopathology; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Glycosylation; Humans; Lipid Peroxidation; Medical sciences; Models, Biological; Oxidation-Reduction; Endocrinopathy; Human; Pathogenesis; Diabetes mellitus; Complication; Oxidation; Radical scavenger; Free radical
• ISSN: 0012-1797; 1939-327X
• DOI: 10.2337/diab.40.4.405

N epsilon-(carboxymethyl)lysine, N epsilon-(carboxymethyl)hydroxylysine, and the fluorescent cross-link pentosidine are formed by sequential glycation and oxidation reactions between reducing sugars and proteins. These compounds, termed glycoxidation products, accumulate in tissue collagen with age and at an accelerated rate in diabetes. Although glycoxidation products are present in only trace concentrations, even in diabetic collagen, studies on glycation and oxidation of model proteins in vitro suggest that these products are biomarkers of more extensive underlying glycative and oxidative damage to the protein. Possible sources of oxidative stress and damage to proteins in diabetes include free radicals generated by autoxidation reactions of sugars and sugar adducts to protein and by autoxidation of unsaturated lipids in plasma and membrane proteins. The oxidative stress may be amplified by a continuing cycle of metabolic stress, tissue damage, and cell death, leading to increased free radical production and compromised free radical inhibitory and scavenger systems, which further exacerbate the oxidative stress. Structural characterization of the cross-links and other products accumulating in collagen in diabetes is needed to gain a better understanding of the relationship between oxidative stress and the development of complications in diabetes. Such studies may lead to therapeutic approaches for limiting the damage from glycation and oxidation reactions and for complementing existing therapy for treatment of the complications of diabetes.